NAIIS has traditionally dedicated 1 day of the in-person meetings in May to influenza and influenza vaccine recap from the prior year and planning for the upcoming year. However, the National Immunization Conference (NIC) is August 12-14, 2024 this year. And, the in-person NAIIS meeting has been moved to August 15-16, 2024 to coordinate with NIC. Both meetings will be at the same location in Atlanta, GA.

Given the need for partners to plan for the respiratory virus season well before August, the NAIIS will hold a series of virtual meetings in May 2024, including two NAIIS webinars May 16 and 23, 2024 and a NAIIS weekly meeting to specifically address RSV prevention and planning.

May 16: Setting the Stage
Today’s webinar will provide level-setting information on end-of-season vaccination uptake for influenza, RSV, and COVID-19 vaccines for different ages and populations and changes in place of vaccination. Information on attitudes about seasonal vaccines by demographic groups will be discussed.

May 23: Overcoming challenges
Today’s webinar will include a provider panel discussion on challenges and pearls for implementing respiratory virus vaccination efforts, a panel of influenza vaccine manufacturers discussing anticipated challenges for 2024-25 and communications planning, and CDC recap of influenza communications from the prior year and plans for 2024-25.

---

NATIONAL ADULT AND INFLUENZA IMMUNIZATION SUMMIT (NAIIS) RESPIRATORY VIRUS VACCINES VIRTUAL MEETINGS

To help partners plan for the respiratory virus vaccination season, the NAIIS will hold two webinars on May 16 and 23, 2024 from 2:00-4:30 PM. A May 9, 2024 regular NAIIS 3:00-4:00 PM call discussed RSV prevention, immunization errors, and tools to prevent errors.

May 16, 2024: Setting the stage for 2024-25 respiratory virus season: where are we and where can we go from here

Moderator
L.J Tan
Immunize.org

2:00-2:20 PM ET
SESSION ONE: OPENING

• Introduction of NAIIS lead organizations
• NCIRD/CDC vision for 2024-25 respiratory virus vaccination implementation
  Brendan Jackson
  NCIRD, CDC
• Q&As PDF

2:20-3:15 PM ET
SESSION TWO: Disease Impact and Virologic Surveillance Overviews

• Influenza surveillance update
  Alicia Budd
  CDC
• RSV and COVID-19 surveillance update
  Ben Silk
  CDC
• Q&As PDF

3:15-4:00 PM ET
SESSION THREE: Vaccine Coverage, Attitudes and Place of Vaccination
SLIDE DECK | Q&As PDF

• Carla Black
  CDC
• Kayla Calhoun
  CDC

4:00-4:30 PM ET
SESSION FOUR: What does payer data reveal about vaccination trends for respiratory virus vaccines?
SLIDE DECK | Q&As PDF

• Mitchell Finkel
  Avalere

May 23, 2024: Hitting reset on influenza and adult vaccination efforts

2:00-2:05 PM ET
SESSION ONE: Recap of May 9 and 16 meetings

• L.J Tan
  Immunize.org

2:05-3:20 PM ET
SESSION TWO: Vaccine Provider Panel Discussion on Recent Challenges and Suggestions to Reset
SLIDE DECK 1 | SLIDE DECK 2
Q&As PDF

• Carolyn Bridges
  Immunize.org
  Moderator
• Susan Lee
  American College of Physicians
• Denton Shanks
  American Academy of Family Physicians
• John O. Beckner
  National Community Pharmacists Association
• Allison Hill
  American Pharmacists Association
• Amy Behrman
  University of Pennsylvania

3:20-3:55 PM ET
SESSION THREE: Manufacturers’ panel on influenza vaccination challenges for upcoming year

• Jim Sherner
  CSL Seqirus
• Adam Lane
  GSK
• Rob Zeiger
  AstraZeneca
• Julian Ritchey
  Sanofi

3:55-4:30 PM ET
SESSION FOUR: CDC Respiratory Virus Vaccines Communications
SLIDE DECK 1 | SLIDE DECK 2

• Dayle Kern
  CDC
• Erin Burns
  CDC
• May Malik
  HHS/ASPA